CHO, YANG JE,LEE, NA GYONG,JANG, JIN WOOK,KIM, KWANG SUNG,YOO, WON IL
申请号：
EP11849214
公开号：
EP2664345A4
申请日:
2011.12.17
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The present invention relates to a pharmaceutical vaccine composition comprising: (a) a pathogen-derived antigen selected from the group consisting of Mycobacterium tuberculosis antigen, Bacillus anthracis antigen, HAV (hepatitis A virus) antigen, HBV (hepatitis B virus) antigen, HCV (hepatitis C virus) antigen, HIV (human mmunodeficiency virus) antigen, influenza virus antigen, HSV (herpes simplex virus) antigen, Hib (Haemophilus influenzae type b) antigen, Neisseria meningitidis antigen, Corynebacterium diphtheriae antigen, Bordetella pertussis antigen, Clostridium tetani antigen and Varicella virus antigen； (b) a deacylated non-toxic LOS (lipooligosaccharide)； and (c) a pharmaceutically acceptable carrier.
